Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I Pharmacokinetic Study of MABp1 in Healthy Volunteers

Trial Profile

A Phase I Pharmacokinetic Study of MABp1 in Healthy Volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bermekimab (Primary)
  • Indications Acne vulgaris; Cachexia; Colorectal cancer; Haematological malignancies; Non-small cell lung cancer; Plaque psoriasis; Pyoderma; Type 2 diabetes mellitus; Vascular restenosis
  • Focus Pharmacokinetics; Registrational
  • Sponsors XBiotech
  • Most Recent Events

    • 26 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 22 Feb 2017 According to a XBiotech media release, dosing of subjects has been completed in this trial.
    • 22 Feb 2017 Status changed from recruiting to active, no longer recruiting based on announcement of dosing completion in an XBiotech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top